179 related articles for article (PubMed ID: 34267684)
1. Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model.
Yardimci A; Ozdede MR; Kelestimur H
Front Psychiatry; 2021; 12():654616. PubMed ID: 34267684
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms and bone mineral density in menopause and postmenopausal women: A still increasing and neglected problem.
Bener A; Saleh NM; Bhugra D
J Family Med Prim Care; 2016; 5(1):143-9. PubMed ID: 27453860
[TBL] [Abstract][Full Text] [Related]
3. Insomnia in Postmenopausal Women: How to Approach and Treat It?
Jeon GH
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256562
[TBL] [Abstract][Full Text] [Related]
4. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
5. A multinational study of sleep disorders during female mid-life.
Blümel JE; Cano A; Mezones-Holguín E; Barón G; Bencosme A; Benítez Z; Bravo LM; Calle A; Flores D; Espinoza MT; Gómez G; Hernández-Bueno JA; Laribezcoa F; Martino M; Lima S; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Sánchez H; Tserotas K; Vallejo MS; Witis S; Zúñiga MC; Chedraui P
Maturitas; 2012 Aug; 72(4):359-66. PubMed ID: 22717489
[TBL] [Abstract][Full Text] [Related]
6. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
Pinkerton JV; Pickar JH; Racketa J; Mirkin S
Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
[TBL] [Abstract][Full Text] [Related]
7. An integrated approach to diagnosing and managing sleep disorders in menopausal women.
Caretto M; Giannini A; Simoncini T
Maturitas; 2019 Oct; 128():1-3. PubMed ID: 31561815
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density in relation to medical and lifestyle risk factors for osteoporosis in premenopausal, menopausal and postmenopausal women in general practice.
McKnight A; Steele K; Mills K; Gilchrist C; Taggart H
Br J Gen Pract; 1995 Jun; 45(395):317-20. PubMed ID: 7619589
[TBL] [Abstract][Full Text] [Related]
9. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
10. Estrogen therapy for osteoporosis in the modern era.
Levin VA; Jiang X; Kagan R
Osteoporos Int; 2018 May; 29(5):1049-1055. PubMed ID: 29520604
[TBL] [Abstract][Full Text] [Related]
11. Selective estrogen modulators in menopause.
Gambacciani M
Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
[TBL] [Abstract][Full Text] [Related]
12. Demographic characteristics and medical aspects of menopausal women in Taiwan.
Chow SN; Huang CC; Lee YT
J Formos Med Assoc; 1997 Oct; 96(10):806-11. PubMed ID: 9343980
[TBL] [Abstract][Full Text] [Related]
13. Treating insomnia improves depression, maladaptive thinking, and hyperarousal in postmenopausal women: comparing cognitive-behavioral therapy for insomnia (CBTI), sleep restriction therapy, and sleep hygiene education.
Kalmbach DA; Cheng P; Arnedt JT; Anderson JR; Roth T; Fellman-Couture C; Williams RA; Drake CL
Sleep Med; 2019 Mar; 55():124-134. PubMed ID: 30785053
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic Approaches.
Tal JZ; Suh SA; Dowdle CL; Nowakowski S
Curr Psychiatry Rev; 2015; 11(1):63-83. PubMed ID: 26478725
[TBL] [Abstract][Full Text] [Related]
15. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal Osteoporosis: Menopause Hormone Therapy and Selective Estrogen Receptor Modulators.
Rani J; Swati S; Meeta M; Singh SH; Tanvir T; Madan A
Indian J Orthop; 2023 Dec; 57(Suppl 1):105-114. PubMed ID: 38107817
[TBL] [Abstract][Full Text] [Related]
17. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates for prevention of postmenopausal osteoporosis.
Ravn P
Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
[TBL] [Abstract][Full Text] [Related]
19. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
de Villiers TJ
Climacteric; 2010 Jun; 13(3):210-8. PubMed ID: 20184423
[TBL] [Abstract][Full Text] [Related]
20. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
Srinivasan V; Zakaria R; Othaman Z; Brzezinski A; Prasad A; Brown GM
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
